Zobrazeno 1 - 10 of 39 pro vyhledávání: '"Qingqiao Zhang"'
1
Akademický článek
Efficacy and safety of camrelizumab plus transarterial chemoembolization in intermediate to advanced hepatocellular carcinoma patients: A prospective, multi-center, real-world study
Autor: Ran You, Qingyu Xu, Qi Wang, Qingqiao Zhang, Weizhong Zhou, Chi Cao, Xiangzhong Huang, Honghai Ji, Penghua Lv, Hao Jiang, You Lu, Yong Jin, Yongjun Li, Long Cheng, Weidong Wang, Hao Xu, Xiaoli Zhu, Guowen Yin
Publikováno v: Frontiers in Oncology, Vol 12 (2022)
ObjectiveCamrelizumab is a newly developed program-death receptor one inhibitor; the real-world evidence about its application in hepatocellular carcinoma (HCC) treatment is lacking. Therefore, this prospective, multi-center, real-world study evaluat
Externí odkaz: https://doaj.org/article/1065ec3626f348e0b22ba5a711c4ca99
Zobrazit plný text záznamu
2
Akademický článek
Review of Budd-Chiari Syndrome
Autor: Maoheng Zu, Hao Xu, Qingqiao Zhang, Yuming Gu, Ning Wei, Wei Xu, Yanfeng Cui, Hongtao Liu
Publikováno v: Journal of Interventional Medicine, Vol 3, Iss 2, Pp 65-76 (2020)
This study aims to report the Budd-Chiari syndrome clinical research status and progress that has occurred in over nearly 30 years in China, and emphasize the value of imaging in facilitating the diagnosis of Budd-Chiari syndrome based on more than 2
Externí odkaz: https://doaj.org/article/aafd993809f14d5eac9e94098633dea2
Zobrazit plný text záznamu
3
Akademický článek
The application and efficacy of stent place for Budd-Chiari syndrome
Autor: Maoheng Zu, Hao Xu, Yuming Gu, Qingqiao Zhang, Ning Wei, Wei Xu, Yanfeng Cui
Publikováno v: Journal of Interventional Medicine, Vol 1, Iss 3, Pp 170-175 (2018)
ABSTRACT: Objective To evaluate the application value and efficacy on stent place for Budd-Chiari syndrome (BCS).Methods From January 1990 to May 2017, 2228 patients with BCS were admitted to our institution. The mean age was 43.3 years. Stents were
Externí odkaz: https://doaj.org/article/4e64977bc0504fe5a9e1938e471b1eff
Zobrazit plný text záznamu
4
Akademický článek
Feasibility and long-term outcomes of hepatic vein recanalization in Budd-Chiari syndrome through intrahepatic collateral pathways.
Autor: Hongru Ma, Yabo Gou, Chao Wang, Jinchang Xiao, Bin Shen, Hongtao Liu, Qianxin Huang, Hao Xu, Maoheng Zu, Qingqiao Zhang
Publikováno v: European Journal of Gastroenterology & Hepatology; Oct2024, Vol. 36 Issue 10, p1230-1237, 8p
Zobrazit plný text záznamu
8
Review of Budd-Chiari Syndrome
Autor: Yuming Gu, Maoheng Zu, Hao Xu, Wei Xu, Qingqiao Zhang, Ning Wei, Hong-tao Liu, Yanfeng Cui
Publikováno v: Journal of Interventional Medicine
Journal of Interventional Medicine, Vol 3, Iss 2, Pp 65-76 (2020)
This study aims to report the Budd-Chiari syndrome clinical research status and progress that has occurred in over nearly 30 years in China, and emphasize the value of imaging in facilitating the diagnosis of Budd-Chiari syndrome based on more than 2
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::592c88f6e7a3a044fdf94af17dd86081
https://doi.org/10.1016/j.jimed.2020.03.002
Zobrazit plný text záznamu
9
The application and efficacy of stent place for Budd-Chiari syndrome
Autor: Maoheng Zu, Hao Xu, Yuming Gu, Qingqiao Zhang, Ning Wei, Wei Xu, Yanfeng Cui
Publikováno v: Journal of Interventional Medicine
Journal of Interventional Medicine, Vol 1, Iss 3, Pp 170-175 (2018)
Objective To evaluate the application value and efficacy on stent place for Budd-Chiari syndrome (BCS).Methods From January 1990 to May 2017, 2228 patients with BCS were admitted to our institution. The mean age was 43.3 years. Stents were placed in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0ac4f75b5164640b25833a7526037adf
http://europepmc.org/articles/PMC8586564
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje